West Pharmaceutical Services Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for West Pharmaceutical Services, Inc. (WST) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income492.70593.40585.90661.80346.20241.70206.90
Depreciation & Amortization155.40137.30120.60122.30109.10103.40104.40
Deferred Income Tax0.0037.50-30.80-42.90-5.8015.300.90
Stock Based Compensation18.7023.3023.7037.5034.000.000.00
Change in Working Capital2.90-20.40-15.00-198.10-11.20-14.90-28.30
Change in Accounts Receivable-58.804.00-35.60-123.50-46.600.000.00
Change in Inventory42.00-13.50-49.80-86.50-73.700.000.00
Change in Accounts Payable2.904.40-2.8016.8036.600.000.00
Change in Other Working Capital16.801.0073.20-4.9073.400.000.00
Other Operating Activities-16.301.0029.20-27.7038.6024.101.60
Net Cash from Operating Activities653.40776.50724.00584.00472.50367.20288.60
Investing Activities
Capital Expenditures-377.00-362.00284.60-253.40174.40126.40-104.70
Acquisitions0.000.000.00-2.200.00-104.000.00
Sales/Maturities of Investments0.000.00-3.602.50-5.102.400.00
Other Investing Activities-1.70-6.70-3.602.50-5.102.403.90
Net Cash from Investing Activities-378.70-368.70-288.20-253.10-179.50-228.00-100.80
Financing Activities
Debt Repayment-27.60-2.40-45.50-2.20-2.30-137.50-0.10
Common Stock Issued0.0051.00-202.8037.10-115.50-83.10-70.80
Common Stock Repurchased-566.60-451.20-222.20-151.90-121.400.000.00
Dividends Paid-59.10-57.0054.10-51.1048.1045.10-42.10
Other Financing Activities30.70-0.10-19.40-7.100.505.400.00
Net Cash from Financing Activities-622.60-459.60-293.60-168.10-137.10-36.80-80.70
Summary
Effect of Forex Changes on Cash-21.4011.40-10.50-15.7020.50-0.70-5.60
Net Change in Cash-369.30-51.80142.20147.10155.90102.40107.10
Cash at Beginning of Period853.90894.30762.60615.50439.10337.40235.90
Cash at End of Period484.60853.90894.30762.60615.50439.10337.40
Free Cash Flow276.40414.50439.40330.60298.10240.80183.90
Supplemental Disclosures
Interest Paid0.506.006.608.008.108.608.40
Income Taxes Paid71.4090.80109.70171.8048.4047.5042.00